Jerry Avorn

Jerry Avorn

Harvard Medical School
在 partners.org 的电子邮件经过验证
被引用次数：122086
pharmacoepidemiology side effects drug policy academic detailing prescription drugs
Steffanie A Strathdee

Steffanie A Strathdee

University of California San Diego
在 ucsd.edu 的电子邮件经过验证
被引用次数：57956
phage therapy prevention of HIV and related infections addiction sex work drug policy
Michael Farrell

Michael Farrell

Professor, Director, National Drug and Alcohol Research Centre, University of New South …
在 unsw.edu.au 的电子邮件经过验证
被引用次数：39856
Addiction Harm Reduction Drug Policy alcohol opioids
Peter Reuter

Peter Reuter

Professor of Public Policy, University of Maryland
在 umd.edu 的电子邮件经过验证
被引用次数：24861
First interest economics of illegal markets Second interest drug policy ...
Kamarulzaman Adeeba

Kamarulzaman Adeeba

Monash University Malaysia
在 monash.edu 的电子邮件经过验证
被引用次数：18900
Infectious Diseases HIV Harm Reduction Drug Policy
Tara Gomes

Tara Gomes

Scientist, St. Michael's Hospital
在 smh.ca 的电子邮件经过验证
被引用次数：17468
Epidemiology drug policy
Rosalie Liccardo Pacula

Rosalie Liccardo Pacula

Professor of Health Policy, Economics and Law, USC Sol Price School of Public Policy
在 healthpolicy.usc.edu 的电子邮件经过验证
被引用次数：16630
health economics drug policy addiction policy
Jonathan Caulkins

Jonathan Caulkins

Carnegie Mellon University
在 andrew.cmu.edu 的电子邮件经过验证
被引用次数：15714
drug policy optimal control terror
Judith Aldridge, Professor of Criminology

Judith Aldridge, Professor of Criminology

University of Manchester
在 manchester.ac.uk 的电子邮件经过验证
被引用次数：8789
Drug use drug markets drug policy
Joseph J Palamar

Joseph J Palamar

New York University School of Medicine
在 nyu.edu 的电子邮件经过验证
被引用次数：7685
drug use drug policy epidemiology
1 - 10